You've probably heard the expression "cash cow," but what does it really mean? The metaphor comes from the dairy industry, where a farmer buys a cow and then receives a steady supply of milk for years to come. In the business world, the equivalent is a company that consistently generates solid cash flow.
Continue Reading Below
Stocks with strong free cash flow (the amount of cash remaining after capital expenditures) often make great investment choices. They're more likely to pay out dividends and to keep those dividends coming. The companies also have more flexibility in reinvesting in their businesses to remain competitive.
Three top stocks that are definitely cash cows are Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), Apple (NASDAQ: AAPL), and Johnson & Johnson (NYSE: JNJ). Here's how they make their big moola (sorry -- the pun was too hard to resist).
Alphabet's free cash flow over the last 12 months totaled almost $28 billion. This great cash flow helped Google report cash, cash equivalents, and marketable securities of $92.4 billion at the end of the first quarter.
How does Alphabet generate its enormous cash flow? Nearly all of it (99%) comes from Google, with a small portion stemming from what the company calls its "other bets," which include Nest home automation and its Verily life sciences division. Within Google, advertising revenue on its search engine and YouTube social media site account for roughly 87% of revenue.
Continue Reading Below
What's particularly great for Alphabet is that its free cash flow continues to grow. Sooner or later, the company will need to do something with the big cash stockpile that it has accumulated. Most likely, Alphabet will make strategic acquisitions, buy back more shares, and/or initiate a dividend. Any of these will reward investors, making Alphabet one of the most attractive cash cow stocks on the market.
Apple generated free cash flow over the last 12 months of nearly $53 billion. Thanks to this strong cash flow, Apple claims a massive cash stockpile totaling $67.1 billion (including cash, cash equivalents, and marketable securities). The company's cash flow also enables it to pay a dividend with a current yield of 1.76%.
While Apple makes money from many popular products and services, its iPhone sales generate 63% of total revenue. This could change in the future, though. One venture capital firm founder thinks that Apple could be developing augmented reality glasses that could be even bigger than the iPhone.
Also, Apple's iPhone sales are only growing by single-digit percentages. By comparison, revenue from the company's second-biggest moneymaker -- services, which includes digital content, AppleCare, Apple Pay, and licensing -- jumped 18% year over year in the first quarter of 2017. Although Apples faces some risks from competition, it seems likely that the company will remain a cash cow for years to come.
Johnson & Johnson
Johnson & Johnson's free cash flow over the last 12 months topped $16 billion. The healthcare giant reported cash, cash equivalents, and marketable securities of $39.3 billion at the end of March. J&J's dividend is one of the most solid in all of healthcare, with a current yield of 2.53% and a 54-year streak of dividend increases.
There isn't much in healthcare that J&J doesn't do. The company's top source of revenue is its pharmaceutical business, which generates around 46% of total sales. Its medical devices segment isn't too far behind, contributing more than 35% of total revenue. J&J's consumer business kicks in the rest of the company's sales.
The company has prioritized acquisitions as a key way of using its cash and cash flow. Earlier this year, J&J acquired Abbott Medical Optics from Abbott Laboratories, bolstering its medical devices business. More recently, the company completed its $30 billion acquisition of Swiss drugmaker Actelion. Although there have been quite a few questions about the price tag paid for Actelion, J&J seems poised to stay ranked as a top cash cow stock.
10 stocks we like better than Johnson & Johnson
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Johnson & Johnson wasn't one of them! That's right -- they think these 10 stocks are even better buys.
Click here to learn about these picks!
*Stock Advisor returns as of July 6, 2017
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Keith Speights owns shares of Alphabet (A shares) and Apple. The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), Apple, and Johnson & Johnson. The Motley Fool has a disclosure policy.